Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Bendamustine and Bortezomib Combination Therapy in Indolent Non-Hodgkin's Lymphoma(NHL)
- First Posted Date
- 2007-01-25
- Last Posted Date
- 2015-04-03
- Lead Sponsor
- Peter Moosmann
- Target Recruit Count
- 12
- Registration Number
- NCT00426855
News
No news found